Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.
口服奥马珠单抗免疫疗法可逆转调节性 T 细胞的 Th2 细胞样程序并恢复其功能
期刊:Clinical and Experimental Allergy
影响因子:5.2
doi:10.1111/cea.13161
Abdel-Gadir A, Schneider L, Casini A, Charbonnier L-M, Little S V, Harrington T, Umetsu D T, Rachid R, Chatila T A
